SMO and medulloblastoma: The developmental origins of medulloblastoma can be analyzed by pairing different Cre drivers with conditional mutations of the SHH receptor components Ptc and Smo directing SHH hyperactivation to broad lineages that include CGNPs or more narrow lineages within the CGNP population.